Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-13 Purchase |
2023-11-13 5:24 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer |
5,000 | $10.29 | $51,448 | 254,800 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 5:49 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $83.74 | $83,740 | 43,000 (Direct) |
View |
| 2021-12-01 Sale |
2021-12-02 7:16 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $81.84 | $81,840 | 44,000 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-02 7:24 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $80.46 | $80,460 | 45,000 (Direct) |
View |
| 2021-10-25 Sale |
2021-10-27 8:13 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $77.59 | $77,590 | 46,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-20 Option Award |
2024-06-21 4:48 pm |
N/A 2034-06-20 |
Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-13 4:30 pm |
N/A 2034-06-12 |
Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director |
22,100 | $0 | 22,100 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:11 pm |
N/A 2034-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer |
250,000 | $0 | 734,145 (Direct) |
View |
| 2024-02-01 Tax Withholding |
2024-02-05 7:11 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer |
20,655 | $11.69 | 734,145 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:20 pm |
N/A 2024-06-27 |
Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 4:26 pm |
N/A 2033-06-13 |
Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-01 7:08 pm |
N/A 2033-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer |
600,000 | $0 | 605,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:30 pm |
N/A 2032-06-14 |
Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:23 pm |
N/A 2032-06-09 |
Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director |
19,872 | $0 | 19,872 (Direct) |
View |
| 2022-05-16 Option Award |
2022-05-20 4:27 pm |
N/A 2032-05-15 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly President & CEO |
2,136,011 | $0 | 2,136,011 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 5:49 pm |
N/A 2030-06-30 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $0 | 43,000 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 5:49 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $47.8 | 43,000 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-02 7:16 pm |
N/A 2030-06-30 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $0 | 44,000 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-02 7:16 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $47.8 | 44,000 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-02 7:24 pm |
N/A 2030-06-30 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $0 | 45,000 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-02 7:24 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $47.8 | 45,000 (Direct) |
View |
| 2021-10-25 Exercise |
2021-10-27 8:13 pm |
N/A 2030-06-30 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $47.8 | 46,000 (Direct) |
View |
| 2021-04-12 Option Award |
2021-06-25 5:00 pm |
N/A 2031-04-12 |
Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director |
54,213 | $0 | 54,213 (Direct) |
View |
Ownership |
2021-06-23 8:40 pm |
N/A 2030-08-13 |
Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director |
0 | $0 | 35,931 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:34 pm |
N/A 2031-06-17 |
Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director |
19,872 | $0 | 19,872 (Direct) |
View |
Ownership |
2021-06-17 5:07 pm |
N/A 2031-05-21 |
Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director |
0 | $0 | 99,483 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-08 5:27 pm |
N/A 2031-06-03 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-07-01 Option Award |
2020-07-01 8:28 pm |
N/A 2030-06-30 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
42,000 | $0 | 42,000 (Direct) |
View |